Pseudotumoral rebound of multiple sclerosis in a pregnant patient after stopping natalizumab.
Mult Scler Relat Disord
; 3(2): 279-81, 2014 Mar.
Article
en En
| MEDLINE
| ID: mdl-25878019
ABSTRACT
Natalizumab is a highly efficacious treatment for active relapsing-remitting multiple sclerosis, dramatically reducing both clinical and radiological signs of inflammation in most patients. The disease course after stopping treatment and especially the emergence of rebound activity are still a matter of debate. We present a case of dramatic reactivation of clinical disease activity with newly emerging pseudotumoral lesions in a patient who stopped treatment due to pregnancy. Both the clinical and radiological presentation suggest a rebound and necessitate close monitoring of patients stopping their treatment during pregnancy, even after a long period of stable disease.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Idioma:
En
Revista:
Mult Scler Relat Disord
Año:
2014
Tipo del documento:
Article